The Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Cell. 2010 Jan 22;140(2):280-93. doi: 10.1016/j.cell.2009.12.041.
SIRT6 is a member of a highly conserved family of NAD(+)-dependent deacetylases with various roles in metabolism, stress resistance, and life span. SIRT6-deficient mice develop normally but succumb to a lethal hypoglycemia early in life; however, the mechanism underlying this hypoglycemia remained unclear. Here, we demonstrate that SIRT6 functions as a histone H3K9 deacetylase to control the expression of multiple glycolytic genes. Specifically, SIRT6 appears to function as a corepressor of the transcription factor Hif1alpha, a critical regulator of nutrient stress responses. Consistent with this notion, SIRT6-deficient cells exhibit increased Hif1alpha activity and show increased glucose uptake with upregulation of glycolysis and diminished mitochondrial respiration. Our studies uncover a role for the chromatin factor SIRT6 as a master regulator of glucose homeostasis and may provide the basis for novel therapeutic approaches against metabolic diseases, such as diabetes and obesity.
SIRT6 是一种高度保守的 NAD(+)依赖去乙酰化酶家族的成员,在代谢、应激抵抗和寿命方面具有多种作用。SIRT6 缺陷型小鼠正常发育,但在生命早期会遭受致命性低血糖的影响;然而,导致这种低血糖的机制仍不清楚。在这里,我们证明 SIRT6 作为组蛋白 H3K9 去乙酰化酶发挥作用,以控制多种糖酵解基因的表达。具体来说,SIRT6 似乎作为转录因子 Hif1alpha 的核心抑制因子发挥作用,Hif1alpha 是营养应激反应的关键调节剂。与这一观点一致的是,SIRT6 缺陷型细胞表现出 Hif1alpha 活性增加,并表现出葡萄糖摄取增加,糖酵解上调,线粒体呼吸减少。我们的研究揭示了染色质因子 SIRT6 作为葡萄糖稳态的主调控因子的作用,可能为治疗代谢性疾病(如糖尿病和肥胖症)提供新的治疗方法的基础。
Transcription. 2010
Cell Death Differ. 2014-11
Am J Physiol Endocrinol Metab. 2017-10-1
PLoS One. 2012-12-11
Oncotarget. 2015-5-10
Cell Commun Signal. 2025-8-4
Metabolites. 2025-5-2
Front Physiol. 2025-5-12
Front Epigenet Epigenom. 2024
Am J Physiol Gastrointest Liver Physiol. 2025-7-1
Ann N Y Acad Sci. 2009-9
Nature. 2009-7-30
Proc Natl Acad Sci U S A. 2009-3-17
J Gerontol A Biol Sci Med Sci. 2009-2